CVE-2026-67558
Mira Hormone Monitor, Mira Android App Authentication bypass by spoofing
The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only, with no cryptographic peripheral authentication, MAC allowlist, or bonded-identity check. An attacker could capture live session token information and inject forged hormone measurements into the victim's cloud record and clinical trend view.
Attack profile
How easy it is to exploit
- Attack vector
- Adjacent network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- Active
What an attacker can affect
- Confidentiality
- High
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
Mira Hormone Monitor, Mira Android App Authentication bypass by spoofing
The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only, with no cryptographic peripheral authentication, MAC allowlist, or bonded-identity check. An attacker could capture live session token information and inject forged hormone measurements into the victim's cloud record and clinical trend view.
- Record
CVE-2026-67558- CVSS 4.0
- 8.2 High
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:A/VC:H/VI:L/VA:N/SC:H/SI:L/SA:N - CVSS 3.1
- 7.4 High
CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:C/C:H/I:L/A:N - Weakness
- CWE-290
- Updated
- 2026-11-02
EUVDEUVD-2026-57006
The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only, with no cryptographic peripheral authentication, MAC allowlist, or bonded-identity check. An attacker could capture live session token information and inject forged hormone measurements into the victim's cloud record and clinical trend view.
- Record
EUVD-2026-57006- CVSS 4.0
- 8.2 High
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:A/VC:H/VI:L/VA:N/SC:H/SI:L/SA:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-cxxh-6vq9-57gc
The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by...
The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only, with no cryptographic peripheral authentication, MAC allowlist, or bonded-identity check. An attacker could capture live session token information and inject forged hormone measurements into the victim's cloud record and clinical trend view.
- Record
GHSA-cxxh-6vq9-57gc- CVSS 4.0
- 8.2 High
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:A/VC:H/VI:L/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 7.4 High
CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:C/C:H/I:L/A:N - Weakness
- CWE-290
- Updated
- 2026-11-02
NVD
The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only, with no cryptographic peripheral authentication, MAC allowlist, or bonded-identity check. An attacker could capture live session token information and inject forged hormone measurements into the victim's cloud record and clinical trend view.
- Record
CVE-2026-67558- CVSS 4.0
- 8.2 High
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:A/VC:H/VI:L/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 7.4 High
CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:C/C:H/I:L/A:N - Weakness
- CWE-290
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2026-67558 is a high vulnerability (CVSS 8.2) in Quanovate Tech Inc. (operating As Mira / Mira Care) Mira Android App, published August 11, 2026. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.27%, the 18th percentile. No source names a fixed version.